Supporting Decisions on Lifestyle Change
Launched by UNIVERSITY OF FLORIDA · Jan 12, 2024
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older
- • Body Mass Index (BMI) ≥ 30 kg/m2 based on self-report body weight and height, or BMI ≥ 27-29.9 kg/m2 with a weight related comorbidity of hypertension, type 2 diabetes, pre-diabetes, dyslipidemia, or obstructive sleep apnea, gastroesophageal reflux disease, or coronary artery disease.
- • Self-report weight ≤ 375 lbs (the maximum weight that BodyTrace scales can accurately detect is 397 lbs, thus 375 lbs provides a buffer to allow detection of at least 20 lbs weight gain).
- • Has a desire to weigh less
- • Has valid email address in Electronic Health Record
- • Has an appointment scheduled with enrolled PCP about 21-28 days after electronic data pull
- • Speaks and reads English
- • Has either WiFi internet access at home or a phone or tablet with a data plan.
- • Exclusion criteria
- • Currently enrolled in evidence-based comprehensive weight loss treatment
- • Pregnant or planning to become pregnant in the next 6 months
- • Currently breastfeeding (or pumping breastmilk) more than 3 times per day.
- • Currently undergoing treatment for cancer
- • Had cardiovascular event in the past 60 days
- • Severe depression symptoms on PHQ-8 (total score ≥20)
- • Inpatient psychiatric treatment in the past 6 months
- • Eating disorder in past 5 years
- • Congestive heart failure resulting in recent (past 6 months) hospitalization or contributing to difficulty breathing or difficulty doing daily activities.
- • Dementia diagnosis
- • Bariatric surgery in the past year or currently undergoing evaluation for bariatric surgery
- • Currently taking doctor-prescribed medication for weight loss
- • Inability to stand on body weight scale independently
- • Impaired hearing
- • Unable to read content on websites without assistance
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Gainesville, Florida, United States
Patients applied
Trial Officials
Megan A McVay, PhD
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported